Tag: pta

Advance Serenity hydrophilic PTA balloon catheter now available in the USA

Cook Medical recently announced that the Advance Serenity hydrophilic percutaneous transluminal angioplasty (PTA) balloon catheter is now available to physicians in the USA. The...

Cook Medical and Surmodics reach distribution agreement for two new vascular...

Cook Medical and Surmodics have announced an agreement in which Cook Medical will distribute two new Surmodics products, hydrophilic percutaneous transluminal angioplasty (PTA) balloon...

VIVA 2019: Ultrasound before angioplasty for BTK lesions may improve outcomes...

Low-frequency, high-intensity ultrasound energy delivery followed by percutaneous transluminal angioplasty (PTA) may improve clinical outcomes in below-the-knee (BTK) lesions without the need for a...

BD announces launch of UltraScore 014 Focused Force PTA Balloon

BD has announced the launch of their UltraScore 014 Focused Force percutaneous transluminal angioplasty (PTA) Balloon. This marks the first scoring balloon with sheath...

Consider intravascular lithotripsy when treating calcified femoropopliteal arteries

 Treating severely calcified arteries by endovascular means is still a challenge, although atherectomy, stents and lithotripsy are all techniques that are employed. Lithotripsy (also...

Serranator Alto serration balloon effective at 30 days in treating critical...

Preliminary 30-day data from the PRELUDE trial investigating the use of the Serranator Alto percutaneous transluminal angioplasty (PTA) serration balloon catheter (Cagent Vascular) have...
Surmodics

Surmodics announces global approvals of 0.014” low-profile PTA balloon dilation catheter

Surmodics has received US Food and Drug Administration (FDA) 510(k) and CE mark clearance for its 0.014” low-profile percutaneous transluminal angioplasty (PTA) balloon dilation...

Cagent Vascular completes enrolment of PRELUDE study using Serranator Alto device

Cagent Vascular has announced the completion of enrolment in the first-in-human PRELUDE study. The purpose of this prospective, single-arm, multicentre feasibility study is to...

QT Vascular enters into asset purchase option agreement with Medtronic

QT Vascular has entered into an asset purchase option agreement with Medtronic for the acquisition of the group's non-drug coated Chocolate percutaneous transluminal angioplasty...

AV Medical’s Chameleon receives expanded indication to include infusion of diagnostic...

AV Medical Technologies has announced that its Chameleon PTA balloon catheter has received FDA clearance for an expanded indication to include infusion of diagnostic...

Cagent Vascular announces FDA 510(k) clearance of Serranator Alto serration balloon...

Cagent Vascular has announced US Food and Drug Administration 510(k) clearance of its lead product, the Serranator Alto percutaneous transluminal angioplasty serration balloon catheter. The Serranator...

Medtronic to distribute QT Vascular’s Chocolate balloon worldwide

QT Vascular has signed a definitive agreement with Medtronic, for the worldwide distribution of its Chocolate percutaneous transluminal angioplasty (PTA) catheter for a period...